MedicaidPrior AuthMedium impact
MAB2022071101
Pennsylvania Medicaid (DHS)·PA · Dermatology, Rheumatology·Provider Bulletin
Effective date
Sep 1, 2022
We identified it
Jun 20, 2026
Summary
Pennsylvania Medical Assistance (Medicaid) updated prior authorization requirements for oral antipsoriatic medications, revising language for clarity but keeping the same medical necessity guidelines. Non-preferred oral antipsoriatics and quantities exceeding limits still require prior authorization.
Action Required
Review updated prior authorization guidelines for oral antipsoriatic medications in Pennsylvania Medicaid patients. Ensure staff are familiar with preferred drug list requirements and quantity limits. Continue obtaining prior authorization for non-preferred oral antipsoriatics and quantities exceeding limits. No workflow changes needed as guidelines remain the same.